Tomoya Sugiyama

This inventor holds 11 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 7 EPO patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2014-2024.

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 72.7

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 10(Granted Patents)

Company Filing History:

11 out of 985

Chugai Seiyaku Kabushiki Kaisha

patents

Years Active: 2014-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11905325 - Recombinant polypeptide production method (2024-02-20),

2. 11028149 - Recombinant polypeptide production method (2021-06-08),

3. 9802993 - Method for producing a cell for protein production by treating a cell overexpressing a taurine transporter with methotrexate (2017-10-31),

4. 9499618 - Method of producing heterogeneous protein (2016-11-22),

5. 9284374 - Method of producing heterogeneous protein (2016-03-15),

6. 9238687 - Method for recombinant production of a desired polypeptide using a mammalian cell co-expressing a taurine transporter polypeptide (2016-01-19),

7. 9181540 - Method for production of polypeptide (2015-11-10),

8. 9068212 - Method for producing a polypeptide using a cell that overexpresses a bicarbonate transporter (2015-06-30),

9. 8796007 - Method for production of polypeptide (2014-08-05),

10. 8741601 - Method for producing a cell capable of high-yield production of heteroproteins (2014-06-03),

11. 8697397 - Method of producing heterogeneous protein (2014-04-15),

Title: The Innovations of Tomoya Sugiyama

Introduction

Tomoya Sugiyama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant polypeptides. With a total of 11 patents to his name, Sugiyama's work has had a substantial impact on protein production methods.

Latest Patents

One of Sugiyama's latest patents is a recombinant polypeptide production method. This innovative method allows for the high-level production of proteins using cultured animal cells. The process involves culturing a cell that expresses the Antibody Production Enhancing Sequence (APES) and introducing DNA encoding the desired polypeptide. APES contains a nucleotide sequence related to nuclear factor κB inhibitor α (NfkBia) and functions to decrease the intracellular expression of NfkBia, thereby enhancing protein production.

Career Highlights

Throughout his career, Tomoya Sugiyama has worked with notable companies such as Chugai Seiyaku Kabushiki Kaisha and Toyota Jidoshokki. His experience in these organizations has contributed to his expertise in biotechnology and innovation.

Collaborations

Sugiyama has collaborated with esteemed colleagues, including Hisahiro Tabuchi and Satoshi Tainaka. These partnerships have fostered a collaborative environment that has led to advancements in their respective fields.

Conclusion

Tomoya Sugiyama's contributions to biotechnology through his innovative methods and collaborations highlight his importance as an inventor. His work continues to influence the production of recombinant polypeptides, showcasing the potential of scientific advancements in this area.